Medicine Compliance Aid Stability

LampreneNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Capsules 50mg, 100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from light. Airtight container. Protect from moisture.
24 April 2015

Lactation Safety Information

Limited published evidence of safety
Significant amounts in breast milk
Pink tint of milk reported
Red coloration of skin and pigmentation reported in breastfed infants
A clinical decision regarding whether a mother with leprosy should breastfeed will need to be made
4 August 2020